Primary Prevention of Cardiovascular Diseases With Statin Therapy
نویسندگان
چکیده
منابع مشابه
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
BACKGROUND While the role of hydroxymethyl glutaryl coenzyme A reductase inhibitors (statins) in secondary prevention of cardiovascular (CV) events and mortality is established, their value for primary prevention is less clear. To clarify the role of statins for patients without CV disease, we performed a meta-analysis of randomized controlled trials (RCTs). METHODS MEDLINE, EMBASE, Cochrane ...
متن کاملStatin therapy for primary prevention of cardiovascular disease.
CLINICAL QUESTION Do statins reduce rates of cardiovascular events when used for primary prevention? BOTTOM LINE When used for primary prevention, statins are associated with lower rates of all-cause mortality, major vascular events, and revascularizations compared with placebo. Statin therapy is not associated with increased rates of life-threatening adverse effects such as cancer.
متن کاملPrimary prevention of cardiovascular diseases.
One of the tasks of primary health care is the prevention of disease. Cardiovascular disease is still the leading cause of death, and there are several sets of guidelines dealing with both primary and secondary prevention. The article overviews the risk factors for cardiovascular disease and the strategies for primary prevention.
متن کاملUse of Aspirin and Statin as primary prevention for cardiovascular diseases
OBJECTIVE To ascertain whether recommendations for the use of Statins and Aspirin as primary prevention in diabetic patients are correctly implemented at our institution. METHODS This cross-sectional study was conducted between February 2014 and April 2014 at the General Practice Department of King Abdulaziz University Hospital. Three hundred twelve patients were included in the study. Data w...
متن کاملPredictors of residual cardiovascular risk in patients on statin therapy for primary prevention.
BACKGROUND Low-density lipoprotein cholesterol-lowering therapy is an important aspect of primary prevention of cardiovascular disease (CVD). Statins are the most widely used drug therapy for achieving low-density lipoprotein goals based on an individual's 10-year risk. However, substantial risk of CVD events still exists even when a person is on statins. We sought to explore the predictors of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2006
ISSN: 0003-9926
DOI: 10.1001/archinte.166.21.2307